ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/29/2025
Back to search
Official data from USPTO
ATORVALIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
01/30/2025
Trademark type
Word
Nice classes
5
Filing date
12/30/2019
Registration date
09/19/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/19/2023
Last transaction
01/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/20/2023
First use in commerce
06/20/2023
Drawing code
4
Owner type
16
Owner location
FARMVILLE, NC
Examiner
KEATING, SHANNON B
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CMP DEVELOPMENT LLC
CMP Pharma, Inc.
Representatives
Vedia Jones-Richardson Olive & Olive, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cardiovascular disorders and cholesterol reduction
Publications
History of USPTO decisions and trademark events.
43 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/19/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/19/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/16/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/15/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/14/2023
IUAF
USE AMENDMENT FILED
07/11/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/11/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/02/2023
EX5G
SOU EXTENSION 5 GRANTED
02/01/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/01/2023
EXT5
SOU EXTENSION 5 FILED
01/17/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/17/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/08/2022
EX4G
SOU EXTENSION 4 GRANTED
06/06/2022
EXT4
SOU EXTENSION 4 FILED
06/06/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/06/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/28/2021
EX3G
SOU EXTENSION 3 GRANTED
10/26/2021
EXT3
SOU EXTENSION 3 FILED
10/26/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/26/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/12/2021
EX2G
SOU EXTENSION 2 GRANTED
02/10/2021
EXT2
SOU EXTENSION 2 FILED
02/10/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/08/2021
EX1G
SOU EXTENSION 1 GRANTED
01/06/2021
EXT1
SOU EXTENSION 1 FILED
01/06/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/06/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2020
PUBO
PUBLISHED FOR OPPOSITION
05/19/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/29/2020
ALIE
ASSIGNED TO LIE
04/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/24/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/24/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/24/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/24/2020
DOCK
ASSIGNED TO EXAMINER
03/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2020
NWAP
NEW APPLICATION ENTERED
01/02/2020
Continuous trademark protection
Get notified about every new filing that threatens ATORVALIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.